Back to Journals » Clinical Ophthalmology » Volume 12

Argus II retinal prosthesis system: a review of patient selection criteria, surgical considerations, and post-operative outcomes

Authors Finn AP, Grewal DS, Vajzovic L

Received 27 February 2018

Accepted for publication 9 May 2018

Published 13 June 2018 Volume 2018:12 Pages 1089—1097

DOI https://doi.org/10.2147/OPTH.S137525

Checked for plagiarism Yes

Review by Single-blind

Peer reviewers approved by Dr Andrew Yee

Peer reviewer comments 4

Editor who approved publication: Dr Scott Fraser


Avni P Finn, Dilraj S Grewal, Lejla Vajzovic

Department of Ophthalmology, Duke University Eye Center, Durham, NC, USA

Abstract: Retinitis pigmentosa (RP) is a group of heterogeneous inherited retinal degenerative disorders characterized by progressive rod and cone dysfunction and ensuing photoreceptor loss. Many patients suffer from legal blindness by their 40s or 50s. Artificial vision is considered once patients have lost all vision to the point of bare light perception or no light perception. The Argus II retinal prosthesis system is one such artificial vision device approved for patients with RP. This review focuses on the factors important for patient selection. Careful pre-operative screening, counseling, and management of patient expectations are critical for the successful implantation and visual rehabilitation of patients with the Argus II device.

Keywords: retinal prosthesis, vision rehabilitation, artificial vision, patient selection, retinitis pigmentosa, retinal degeneration, low vision

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]